{"id": "article-22386_0", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity", "content": "Graham-Little-Piccardi-Lasseur syndrome (GLPLS) is a\u00a0variant of lichen planopilaris, the follicular form of lichen planus.\u00a0GLPLS is one of\u00a03\u00a0lichen planopilaris variants alongside frontal fibrosing alopecia and classic lichen planopilaris.\u00a0The condition's\u00a0etiology remains uncertain, but a T-cell-mediated autoimmune mechanism is believed to be involved.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity. Graham-Little-Piccardi-Lasseur syndrome (GLPLS) is a\u00a0variant of lichen planopilaris, the follicular form of lichen planus.\u00a0GLPLS is one of\u00a03\u00a0lichen planopilaris variants alongside frontal fibrosing alopecia and classic lichen planopilaris.\u00a0The condition's\u00a0etiology remains uncertain, but a T-cell-mediated autoimmune mechanism is believed to be involved."}
{"id": "article-22386_1", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity", "content": "GLPLS symptoms typically start with hyperkeratotic papules appearing on the trunk and extremities before alopecia develops. GLPLS is characterized by multifocal, patchy, cicatricial alopecia on the scalp, noncicatricial alopecia in the axillae and perineum, and follicular hyperkeratosis on the trunk and extremities.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity. GLPLS symptoms typically start with hyperkeratotic papules appearing on the trunk and extremities before alopecia develops. GLPLS is characterized by multifocal, patchy, cicatricial alopecia on the scalp, noncicatricial alopecia in the axillae and perineum, and follicular hyperkeratosis on the trunk and extremities."}
{"id": "article-22386_2", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity", "content": "The diagnosis relies on clinical presentation, histopathological analysis, and exclusion of similar conditions. Treatment focuses on\u00a0interrupting disease progression, relieving symptoms, and enhancing cosmesis through various modalities,\u00a0including topical and systemic medications, surgical interventions, and patient support. Evaluation and treatment involve an interprofessional team. Interventions must be tailored to each patient's needs and monitored for efficacy and safety.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity. The diagnosis relies on clinical presentation, histopathological analysis, and exclusion of similar conditions. Treatment focuses on\u00a0interrupting disease progression, relieving symptoms, and enhancing cosmesis through various modalities,\u00a0including topical and systemic medications, surgical interventions, and patient support. Evaluation and treatment involve an interprofessional team. Interventions must be tailored to each patient's needs and monitored for efficacy and safety."}
{"id": "article-22386_3", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity", "content": "This activity for healthcare professionals\u00a0is designed to enhance\u00a0the learner\u2019s competence when\u00a0evaluating\u00a0and managing GLPLS. Clinicians develop\u00a0proficiency in recognizing its clinical manifestations, understanding its pathophysiology, and implementing appropriate treatment modalities.\u00a0Greater competence leads to improved interprofessional collaboration and patient care, enhancing prognosis and quality of life for affected individuals.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity. This activity for healthcare professionals\u00a0is designed to enhance\u00a0the learner\u2019s competence when\u00a0evaluating\u00a0and managing GLPLS. Clinicians develop\u00a0proficiency in recognizing its clinical manifestations, understanding its pathophysiology, and implementing appropriate treatment modalities.\u00a0Greater competence leads to improved interprofessional collaboration and patient care, enhancing prognosis and quality of life for affected individuals."}
{"id": "article-22386_4", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity", "content": "Objectives: Identify\u00a0the\u00a0signs and symptoms suggestive\u00a0of Graham-Little-Piccardi-Lasseur syndrome. Develop a clinically guided diagnostic plan for an individual with suspected\u00a0Graham-Little-Piccardi-Lasseur syndrome. Implement individualized management strategies for patients with\u00a0Graham-Little-Piccardi-Lasseur syndrome. Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients\u00a0with Graham-Little-Piccardi-Lasseur syndrome. Access free multiple choice questions on this topic.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Continuing Education Activity. Objectives: Identify\u00a0the\u00a0signs and symptoms suggestive\u00a0of Graham-Little-Piccardi-Lasseur syndrome. Develop a clinically guided diagnostic plan for an individual with suspected\u00a0Graham-Little-Piccardi-Lasseur syndrome. Implement individualized management strategies for patients with\u00a0Graham-Little-Piccardi-Lasseur syndrome. Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients\u00a0with Graham-Little-Piccardi-Lasseur syndrome. Access free multiple choice questions on this topic."}
{"id": "article-22386_5", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Graham-Little-Piccardi-Lasseur Syndrome Overview", "content": "Graham-Little-Piccardi-Lasseur Syndrome (GLPLS) is a rare\u00a0subtype of lichen planopilaris, first discovered by Piccardi in 1913 and\u00a0further characterized\u00a02 years later by Ernst Graham Little in a mutual patient with Lasseur. [1] Lichen planopilaris is\u00a0a follicular variant of lichen planus.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Graham-Little-Piccardi-Lasseur Syndrome Overview. Graham-Little-Piccardi-Lasseur Syndrome (GLPLS) is a rare\u00a0subtype of lichen planopilaris, first discovered by Piccardi in 1913 and\u00a0further characterized\u00a02 years later by Ernst Graham Little in a mutual patient with Lasseur. [1] Lichen planopilaris is\u00a0a follicular variant of lichen planus."}
{"id": "article-22386_6", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Graham-Little-Piccardi-Lasseur Syndrome Overview", "content": "Lichen planopilaris' 3\u00a0presentations include\u00a0GLPLS, frontal fibrosing alopecia, and classic lichen planopilaris. [2] Classic lichen planopilaris\u00a0is a chronic inflammatory process\u00a0manifesting as patchy progressive cicatricial scalp alopecia. Frontal fibrosing alopecia presents with band-like cicatricial alopecia on the scalp's frontal and temporal zones. [3] [4] GLPLS is characterized by multifocal, patchy, cicatricial alopecia on the scalp, noncicatricial alopecia in the axillae and perineum, and follicular hyperkeratosis on the trunk and extremities. [5] [6] GLPLS symptoms\u00a0may occur in any order, often starting with hyperkeratotic papules on the trunk and extremities before alopecia develops in any location (see Image. Lichen Planopilaris).", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Graham-Little-Piccardi-Lasseur Syndrome Overview. Lichen planopilaris' 3\u00a0presentations include\u00a0GLPLS, frontal fibrosing alopecia, and classic lichen planopilaris. [2] Classic lichen planopilaris\u00a0is a chronic inflammatory process\u00a0manifesting as patchy progressive cicatricial scalp alopecia. Frontal fibrosing alopecia presents with band-like cicatricial alopecia on the scalp's frontal and temporal zones. [3] [4] GLPLS is characterized by multifocal, patchy, cicatricial alopecia on the scalp, noncicatricial alopecia in the axillae and perineum, and follicular hyperkeratosis on the trunk and extremities. [5] [6] GLPLS symptoms\u00a0may occur in any order, often starting with hyperkeratotic papules on the trunk and extremities before alopecia develops in any location (see Image. Lichen Planopilaris)."}
{"id": "article-22386_7", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Graham-Little-Piccardi-Lasseur Syndrome Overview", "content": "GLPLS\u00a0constitutes a small fraction of lichen planopilaris cases. The condition predominantly affects\u00a0white women, with onset typically between 30 and 70 years old. Correlations exist with various factors such as\u00a0hepatitis B vaccination, androgen insensitivity syndrome, HLA DR-1 positivity (in a mother and daughter), vitamin A deficiency, hormonal dysfunction, and neuropsychological issues.\u00a0Managing GLPLS focuses on immune response reduction to prevent follicular scarring, though\u00a0reliable\u00a0therapeutic regimens are still lacking. Research suggests JAK inhibition with tofacitinib may normalize interferon-mediated (IFN-mediated) T-cell chemotaxis, potentially preventing infundibular inflammation. Despite theoretical advancements, healthcare professionals struggle to fully treat patients, emphasizing the need for\u00a0better\u00a0preventive measures to mitigate long-term complications.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Graham-Little-Piccardi-Lasseur Syndrome Overview. GLPLS\u00a0constitutes a small fraction of lichen planopilaris cases. The condition predominantly affects\u00a0white women, with onset typically between 30 and 70 years old. Correlations exist with various factors such as\u00a0hepatitis B vaccination, androgen insensitivity syndrome, HLA DR-1 positivity (in a mother and daughter), vitamin A deficiency, hormonal dysfunction, and neuropsychological issues.\u00a0Managing GLPLS focuses on immune response reduction to prevent follicular scarring, though\u00a0reliable\u00a0therapeutic regimens are still lacking. Research suggests JAK inhibition with tofacitinib may normalize interferon-mediated (IFN-mediated) T-cell chemotaxis, potentially preventing infundibular inflammation. Despite theoretical advancements, healthcare professionals struggle to fully treat patients, emphasizing the need for\u00a0better\u00a0preventive measures to mitigate long-term complications."}
{"id": "article-22386_8", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle", "content": "Hair follicles\u00a0consist of\u00a0upper (permanent) and lower (transitory) segments.\u00a0The upper segment comprises the infundibulum, extending from the epidermis to the sebaceous duct, and the isthmus, which\u00a0houses\u00a0stem cells at the bulge region.\u00a0The lower segment is divided into the trunk (stem) and the bulb, with the trunk extending\u00a0from the arrector pili muscle's insertion to the bulb's cornified part (see Image . The Common Integument, Section of Skin).\u00a0The bulb becomes completely keratinized beyond\u00a0this\u00a0region, known as Adamson\u2019s fringe A, stretching to the hair follicle's base.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle. Hair follicles\u00a0consist of\u00a0upper (permanent) and lower (transitory) segments.\u00a0The upper segment comprises the infundibulum, extending from the epidermis to the sebaceous duct, and the isthmus, which\u00a0houses\u00a0stem cells at the bulge region.\u00a0The lower segment is divided into the trunk (stem) and the bulb, with the trunk extending\u00a0from the arrector pili muscle's insertion to the bulb's cornified part (see Image . The Common Integument, Section of Skin).\u00a0The bulb becomes completely keratinized beyond\u00a0this\u00a0region, known as Adamson\u2019s fringe A, stretching to the hair follicle's base."}
{"id": "article-22386_9", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle", "content": "The follicular bulb houses the dermal papilla, providing blood supply and nutrients through a central capillary. The bulb also\u00a0contains progenitor cells, dendritic melanocytes, and\u00a03 internal hair sheath layers\u2014Henle, Huxley, and cuticle\u2014along with the external root\u00a0sheath\u00a0and vitreous membrane (basement membrane). The hair shaft has a cuticle, cortex, and medulla and becomes visible at higher levels of the follicle (see Image . Hair Follicle Transverse Section). The internal hair sheath merges into a single, fully keratinized stratum, while the external root sheath increases in layers. Desquamation occurs in the upper trunk\u00a0portions of the internal hair sheath, while keratinization happens in the external root sheath. The follicle exhibits keratinization similar to the epidermis\u00a0at the infundibulum's level, with a distinguishable granular layer and stratum corneum.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle. The follicular bulb houses the dermal papilla, providing blood supply and nutrients through a central capillary. The bulb also\u00a0contains progenitor cells, dendritic melanocytes, and\u00a03 internal hair sheath layers\u2014Henle, Huxley, and cuticle\u2014along with the external root\u00a0sheath\u00a0and vitreous membrane (basement membrane). The hair shaft has a cuticle, cortex, and medulla and becomes visible at higher levels of the follicle (see Image . Hair Follicle Transverse Section). The internal hair sheath merges into a single, fully keratinized stratum, while the external root sheath increases in layers. Desquamation occurs in the upper trunk\u00a0portions of the internal hair sheath, while keratinization happens in the external root sheath. The follicle exhibits keratinization similar to the epidermis\u00a0at the infundibulum's level, with a distinguishable granular layer and stratum corneum."}
{"id": "article-22386_10", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle", "content": "Hair can be classified into\u00a03 types: lanugo, vellus, and terminal. Lanugo hair is fine and covers the fetus during development, typically disappearing after birth. Vellus hair is less than 1 cm long and has a diameter of less\u00a0than 0.03 mm.\u00a0Vellus hair lacks\u00a0a medulla, and its bulb is\u00a0located\u00a0in the upper dermis. Terminal hair is longer than 1 cm and has a diameter greater than 0.06 mm.\u00a0This hair type possesses a cortex and a medulla, and its bulb is\u00a0located\u00a0in the subcutaneous tissue.\u00a0Terminal hair\u00a0may be categorized into androgen-dependent areas (eg, scalp, beard, chest, axillae, and pubic region) and androgen-independent areas (eg, eyebrows and eyelashes).\u00a0Androgens do not influence vellus hair.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle. Hair can be classified into\u00a03 types: lanugo, vellus, and terminal. Lanugo hair is fine and covers the fetus during development, typically disappearing after birth. Vellus hair is less than 1 cm long and has a diameter of less\u00a0than 0.03 mm.\u00a0Vellus hair lacks\u00a0a medulla, and its bulb is\u00a0located\u00a0in the upper dermis. Terminal hair is longer than 1 cm and has a diameter greater than 0.06 mm.\u00a0This hair type possesses a cortex and a medulla, and its bulb is\u00a0located\u00a0in the subcutaneous tissue.\u00a0Terminal hair\u00a0may be categorized into androgen-dependent areas (eg, scalp, beard, chest, axillae, and pubic region) and androgen-independent areas (eg, eyebrows and eyelashes).\u00a0Androgens do not influence vellus hair."}
{"id": "article-22386_11", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle", "content": "The hair follicle's lower segment is involved in the hair growth cycle. About 85% to 100% of scalp hairs are typically in the anagen phase, which lasts 2 to 7 years.\u00a0Around 1% of scalp hairs exist in the catagen phase,\u00a0a period\u00a0lasting 2 to 3 weeks. Matrix cell apoptosis occurs during this period, thinning the lower segment.\u00a0The vitreous membrane and lower hair shaft thicken, surrounded solely by the external root sheath\u00a0and\u00a0form\u00a0a \u201cclub hair\u201d appearance.\u00a0Telogen\u00a0is the resting phase, comprising 0% to 15% of scalp hairs. This stage\u00a0lasts about 100 days\u00a0and precedes the initiation of new hair growth and another cycle. [7] [8]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Introduction -- Hair Histology and\u00a0the Hair Cycle. The hair follicle's lower segment is involved in the hair growth cycle. About 85% to 100% of scalp hairs are typically in the anagen phase, which lasts 2 to 7 years.\u00a0Around 1% of scalp hairs exist in the catagen phase,\u00a0a period\u00a0lasting 2 to 3 weeks. Matrix cell apoptosis occurs during this period, thinning the lower segment.\u00a0The vitreous membrane and lower hair shaft thicken, surrounded solely by the external root sheath\u00a0and\u00a0form\u00a0a \u201cclub hair\u201d appearance.\u00a0Telogen\u00a0is the resting phase, comprising 0% to 15% of scalp hairs. This stage\u00a0lasts about 100 days\u00a0and precedes the initiation of new hair growth and another cycle. [7] [8]"}
{"id": "article-22386_12", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Etiology", "content": "GLPLS' etiology is an enigma.\u00a0Most schools of thought attribute GLPLS symptoms to a T-cell-mediated autoimmune process. [9] Mechanisms such as altered integrin expression and IFN-\u03b3\u00a0dysregulation, present in lichen planopilaris, likely contribute to GLPLS. Inflammation and altered integrin expression may lead to cicatricial alopecia, with affected follicular roots showing positive anagen hair pull tests. [10] [11] Rodriguez-Bayona et al. reported strong autoimmune reactivity to a centromere-specific protein, inner centromere protein or \"INCENP,\" suggesting mitotic cellular deficits. Although further investigation is needed on INCENP autoantibody prevalence in GLPLS, this finding marks the first GLPLS-linked antibody. [12] Familial\u00a0GLPLS across\u00a03 generations has also been reported recently. [13]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Etiology. GLPLS' etiology is an enigma.\u00a0Most schools of thought attribute GLPLS symptoms to a T-cell-mediated autoimmune process. [9] Mechanisms such as altered integrin expression and IFN-\u03b3\u00a0dysregulation, present in lichen planopilaris, likely contribute to GLPLS. Inflammation and altered integrin expression may lead to cicatricial alopecia, with affected follicular roots showing positive anagen hair pull tests. [10] [11] Rodriguez-Bayona et al. reported strong autoimmune reactivity to a centromere-specific protein, inner centromere protein or \"INCENP,\" suggesting mitotic cellular deficits. Although further investigation is needed on INCENP autoantibody prevalence in GLPLS, this finding marks the first GLPLS-linked antibody. [12] Familial\u00a0GLPLS across\u00a03 generations has also been reported recently. [13]"}
{"id": "article-22386_13", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Epidemiology", "content": "GLPLS mainly affects\u00a0white\u00a0women. The average onset age\u00a0varies from 30 to 70 years\u00a0old. [14] This lichen planopilaris variant comprises a small portion of the overall cases.\u00a0A\u00a0study\u00a0involving 80 individuals with lichen planopilaris reported only\u00a01 case consistent with GLPLS. The condition correlates with various factors, including hepatitis B vaccination, androgen insensitivity syndrome, HLA DR-1 positivity in a mother and daughter, vitamin A deficiency, hormonal dysfunction, and neuropsychological issues. [15]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Epidemiology. GLPLS mainly affects\u00a0white\u00a0women. The average onset age\u00a0varies from 30 to 70 years\u00a0old. [14] This lichen planopilaris variant comprises a small portion of the overall cases.\u00a0A\u00a0study\u00a0involving 80 individuals with lichen planopilaris reported only\u00a01 case consistent with GLPLS. The condition correlates with various factors, including hepatitis B vaccination, androgen insensitivity syndrome, HLA DR-1 positivity in a mother and daughter, vitamin A deficiency, hormonal dysfunction, and neuropsychological issues. [15]"}
{"id": "article-22386_14", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Pathophysiology", "content": "Pilosebaceous unit damage is crucial in GLPLS pathogenesis. Lesional skin exhibits increased IFN-\u03b3-induced chemokines, recruiting cytotoxic T-cells to the follicular infundibulum. [16] IFN-\u03b3 signaling pathway dysregulation increases major histocompatibility complex classes 1 and 2 expression, enhancing antigenic presentation to T-cells. Damage to the chromosomal passenger protein INCENP impedes microtubule binding, causing mislocalization and dysfunction of chromosome passenger complexes.\u00a0Consequently, chromosomal segregation, central spindle formation, and cytoplasmic allocation are impaired. [17] [18] These alterations create metaphase abnormalities that\u00a0reduce\u00a0overall mitotic function.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Pathophysiology. Pilosebaceous unit damage is crucial in GLPLS pathogenesis. Lesional skin exhibits increased IFN-\u03b3-induced chemokines, recruiting cytotoxic T-cells to the follicular infundibulum. [16] IFN-\u03b3 signaling pathway dysregulation increases major histocompatibility complex classes 1 and 2 expression, enhancing antigenic presentation to T-cells. Damage to the chromosomal passenger protein INCENP impedes microtubule binding, causing mislocalization and dysfunction of chromosome passenger complexes.\u00a0Consequently, chromosomal segregation, central spindle formation, and cytoplasmic allocation are impaired. [17] [18] These alterations create metaphase abnormalities that\u00a0reduce\u00a0overall mitotic function."}
{"id": "article-22386_15", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Histopathology", "content": "Histopathologic examination of cicatricial alopecia areas in GLPLS reveals a dilated follicular lumen\u00a0superior to the sebaceous gland with a dense hyperkeratotic plug in the infundibulum's lower portion. Nearby epithelium peripheral to the follicular infundibulum shows hypergranulosis, vacuolar keratinocyte\u00a0degradation, and a lymphocytic infiltrate obscuring the dermal-epidermal junction, with increased dense collagen bundles at the follicular base. Examination of hyperkeratotic papules on the trunk and extremities shows expanded keratin-filled follicular openings, vacuolar degradation of adjacent keratinocytes, and a lymphohistiocytic infiltrate at the dermal-epidermal junction. [19]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Histopathology. Histopathologic examination of cicatricial alopecia areas in GLPLS reveals a dilated follicular lumen\u00a0superior to the sebaceous gland with a dense hyperkeratotic plug in the infundibulum's lower portion. Nearby epithelium peripheral to the follicular infundibulum shows hypergranulosis, vacuolar keratinocyte\u00a0degradation, and a lymphocytic infiltrate obscuring the dermal-epidermal junction, with increased dense collagen bundles at the follicular base. Examination of hyperkeratotic papules on the trunk and extremities shows expanded keratin-filled follicular openings, vacuolar degradation of adjacent keratinocytes, and a lymphohistiocytic infiltrate at the dermal-epidermal junction. [19]"}
{"id": "article-22386_16", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- History and Physical -- History", "content": "A thorough\u00a0clinical evaluation is key to diagnosing GLPLS. On history, patients with\u00a0this condition typically present with a unique hair loss pattern characterized by multifocal, patchy alopecia with hair follicle scarring (cicatricial). Patients may also exhibit noncicatricial alopecia in the axillae and perineum.\u00a0Follicular hyperkeratosis\u00a0is often reported on the trunk and extremities.\u00a0Symptoms are gradual in onset, with hyperkeratotic papules often appearing before hair loss. These papules may evolve into hyperkeratotic plaques over time. Information that may help assess for secondary alopecia causes include the amount of hair loss, the presence of psychosocial stress, or endocrinological abnormalities.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- History and Physical -- History. A thorough\u00a0clinical evaluation is key to diagnosing GLPLS. On history, patients with\u00a0this condition typically present with a unique hair loss pattern characterized by multifocal, patchy alopecia with hair follicle scarring (cicatricial). Patients may also exhibit noncicatricial alopecia in the axillae and perineum.\u00a0Follicular hyperkeratosis\u00a0is often reported on the trunk and extremities.\u00a0Symptoms are gradual in onset, with hyperkeratotic papules often appearing before hair loss. These papules may evolve into hyperkeratotic plaques over time. Information that may help assess for secondary alopecia causes include the amount of hair loss, the presence of psychosocial stress, or endocrinological abnormalities."}
{"id": "article-22386_17", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- History and Physical -- Physical Examination", "content": "Physical examination should include a\u00a0full-body skin check, noting the multifocal, patchy cicatricial scalp hair loss and nonscarring perineal and axillary alopecia. The trunk and extremities may have\u00a0hyperkeratotic papules with surrounding perifollicular erythema, which are\u00a0key\u00a0features of GLPLS.\u00a0An anagen hair pull test is often positive in GLPLS because the hair follicles are weakly anchored in\u00a0affected individuals. Dermoscopy may show perifollicular erythema and scaling in alopecic areas (see Image .\u00a0Dermoscopic and Clinical Findings in Lichen Planopilaris).", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- History and Physical -- Physical Examination. Physical examination should include a\u00a0full-body skin check, noting the multifocal, patchy cicatricial scalp hair loss and nonscarring perineal and axillary alopecia. The trunk and extremities may have\u00a0hyperkeratotic papules with surrounding perifollicular erythema, which are\u00a0key\u00a0features of GLPLS.\u00a0An anagen hair pull test is often positive in GLPLS because the hair follicles are weakly anchored in\u00a0affected individuals. Dermoscopy may show perifollicular erythema and scaling in alopecic areas (see Image .\u00a0Dermoscopic and Clinical Findings in Lichen Planopilaris)."}
{"id": "article-22386_18", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Evaluation", "content": "Skin biopsy and physical examination findings serve as the primary diagnostic methods for GLPLS. Histological analysis of cicatricial areas and hyperkeratotic papules reveals lichen planopilaris features, indicating perifollicular inflammation leading to pilosebaceous destruction (see Image .\u00a0Lichen\u00a0Planopilaris Histopathology). Late-stage GLPLS may involve arrector pili muscle corruption. Clinical evaluation typically shows erythematous follicular papules varying in size from 1 to 4 mm, nonscarring alopecia in the perineum and axillae, and patchy\u00a0cicatricial scalp alopecia.\u00a0Hyperkeratotic papules are common on the trunk, thighs, inner and outer arms, and wrists, with or without pruritus. Hyperkeratotic papules may precede scalp alopecia onset, but symptom order varies. [20]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Evaluation. Skin biopsy and physical examination findings serve as the primary diagnostic methods for GLPLS. Histological analysis of cicatricial areas and hyperkeratotic papules reveals lichen planopilaris features, indicating perifollicular inflammation leading to pilosebaceous destruction (see Image .\u00a0Lichen\u00a0Planopilaris Histopathology). Late-stage GLPLS may involve arrector pili muscle corruption. Clinical evaluation typically shows erythematous follicular papules varying in size from 1 to 4 mm, nonscarring alopecia in the perineum and axillae, and patchy\u00a0cicatricial scalp alopecia.\u00a0Hyperkeratotic papules are common on the trunk, thighs, inner and outer arms, and wrists, with or without pruritus. Hyperkeratotic papules may precede scalp alopecia onset, but symptom order varies. [20]"}
{"id": "article-22386_19", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Treatment / Management", "content": "Managing GLPLS\u00a0remains elusive\u00a0due to the lack\u00a0of a dominant therapeutic regimen. Treatment\u00a0focuses on mitigating the immunological response before follicular scarring occurs. Novel research suggests that JAK inhibition with tofacitinib normalizes IFN-mediated T-cell chemotaxis, preventing infundibular inflammation.\u00a0A case series of 8 lichen planopilaris patients reported that a twice-daily 5mg dose of tofacitinib resulted in a 30%\u00a0to 94% improvement in disease severity.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Treatment / Management. Managing GLPLS\u00a0remains elusive\u00a0due to the lack\u00a0of a dominant therapeutic regimen. Treatment\u00a0focuses on mitigating the immunological response before follicular scarring occurs. Novel research suggests that JAK inhibition with tofacitinib normalizes IFN-mediated T-cell chemotaxis, preventing infundibular inflammation.\u00a0A case series of 8 lichen planopilaris patients reported that a twice-daily 5mg dose of tofacitinib resulted in a 30%\u00a0to 94% improvement in disease severity."}
{"id": "article-22386_20", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Treatment / Management", "content": "Zegarska\u00a0et al\u00a0described a patient treated with prednisone 30 mg for 2 weeks, followed by a reduction to 20 mg, alongside psoralen and ultraviolet light A at 12 joules. This regimen moderately improved follicular hyperkeratosis on the trunk and extremities. [21] The follicular papules were reduced, but\u00a0cicatricial scalp alopecia and\u00a0noncicatricial axillary and perineal\u00a0hair loss did not\u00a0diminish. [22]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Treatment / Management. Zegarska\u00a0et al\u00a0described a patient treated with prednisone 30 mg for 2 weeks, followed by a reduction to 20 mg, alongside psoralen and ultraviolet light A at 12 joules. This regimen moderately improved follicular hyperkeratosis on the trunk and extremities. [21] The follicular papules were reduced, but\u00a0cicatricial scalp alopecia and\u00a0noncicatricial axillary and perineal\u00a0hair loss did not\u00a0diminish. [22]"}
{"id": "article-22386_21", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Treatment / Management", "content": "Other\u00a0therapies that have also been used to manage GLPLS\u00a0include\u00a0intralesional glucocorticoids, topical glucocorticoids, systemic glucocorticoids, cyclosporine,\u00a0tacrolimus\u00a0ointment, and systemic retinoids. Most treatment methods reduce perifollicular erythema and inflammation without affecting scalp, perineal, and axillary hair loss.\u00a0Recent reports have documented successful treatment of GLPLS using narrow-band UVB phototherapy. [23]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Treatment / Management. Other\u00a0therapies that have also been used to manage GLPLS\u00a0include\u00a0intralesional glucocorticoids, topical glucocorticoids, systemic glucocorticoids, cyclosporine,\u00a0tacrolimus\u00a0ointment, and systemic retinoids. Most treatment methods reduce perifollicular erythema and inflammation without affecting scalp, perineal, and axillary hair loss.\u00a0Recent reports have documented successful treatment of GLPLS using narrow-band UVB phototherapy. [23]"}
{"id": "article-22386_22", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Differential Diagnosis", "content": "The differential diagnosis\u00a0of GLPLS includes the following conditions: Classical lichen planopilaris Pseudopelade\u00a0of Brocq [24] Frontal fibrosing alopecia Lichen spinulosus Androgen insensitivity syndrome Discoid lupus erythematosus [25] Secondary syphilis [26] Addison disease [27] These conditions often manifest with skin lesions and scalp conditions resembling GLPLS symptoms. A thorough clinical investigation and appropriate diagnostic testing can guide management strategies.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Differential Diagnosis. The differential diagnosis\u00a0of GLPLS includes the following conditions: Classical lichen planopilaris Pseudopelade\u00a0of Brocq [24] Frontal fibrosing alopecia Lichen spinulosus Androgen insensitivity syndrome Discoid lupus erythematosus [25] Secondary syphilis [26] Addison disease [27] These conditions often manifest with skin lesions and scalp conditions resembling GLPLS symptoms. A thorough clinical investigation and appropriate diagnostic testing can guide management strategies."}
{"id": "article-22386_23", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Prognosis", "content": "GLPLS' course is often drawn out\u00a0but may improve with treatment. Still, full alopecic symptom\u00a0resolution with current treatment modalities is rare. Data on the average disease duration of GLPLS\u00a0are limited, though some cases persist for over 20 years. Zegarska et al report durations ranging from 6 months to 10 years. [22] Adequate medical management may significantly improve the prognosis, particularly in reducing hyperkeratotic papules on the trunk and extremities.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Prognosis. GLPLS' course is often drawn out\u00a0but may improve with treatment. Still, full alopecic symptom\u00a0resolution with current treatment modalities is rare. Data on the average disease duration of GLPLS\u00a0are limited, though some cases persist for over 20 years. Zegarska et al report durations ranging from 6 months to 10 years. [22] Adequate medical management may significantly improve the prognosis, particularly in reducing hyperkeratotic papules on the trunk and extremities."}
{"id": "article-22386_24", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Complications", "content": "GLPLS can cause considerable psychosocial distress as it can significantly change a person's appearance. However, the condition does\u00a0not exhibit systemic manifestations. Further research on INCENP's role, especially in overall mitotic function, may uncover associated morbidities, but none have been identified. The GLPLS complication\u00a0that primarily lasts is follicular scarring from infundibular inflammation, permanently damaging pilosebaceous units, particularly in\u00a0the scalp.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Complications. GLPLS can cause considerable psychosocial distress as it can significantly change a person's appearance. However, the condition does\u00a0not exhibit systemic manifestations. Further research on INCENP's role, especially in overall mitotic function, may uncover associated morbidities, but none have been identified. The GLPLS complication\u00a0that primarily lasts is follicular scarring from infundibular inflammation, permanently damaging pilosebaceous units, particularly in\u00a0the scalp."}
{"id": "article-22386_25", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Deterrence and Patient Education", "content": "Patients with GLPLS require comprehensive prognosis and treatment explanations to establish realistic expectations. Many patients opt out of treatment because current therapies often do not address the condition's alopecic aspects. Treatments cannot reverse cicatricial damage, but early intervention may slow noncicatricial alopecia, cicatricial scalp alopecia, and hyperkeratotic papule formation progression. Clarifying therapy goals can enhance compliance and foster stronger patient-physician relationships.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Deterrence and Patient Education. Patients with GLPLS require comprehensive prognosis and treatment explanations to establish realistic expectations. Many patients opt out of treatment because current therapies often do not address the condition's alopecic aspects. Treatments cannot reverse cicatricial damage, but early intervention may slow noncicatricial alopecia, cicatricial scalp alopecia, and hyperkeratotic papule formation progression. Clarifying therapy goals can enhance compliance and foster stronger patient-physician relationships."}
{"id": "article-22386_26", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Pearls and Other Issues", "content": "GLPLS is a complex clinical\u00a0entity presenting with multifocal, patchy cicatricial scalp alopecia, noncicatricial\u00a0alopecia in areas like the axillae and perineum, and hyperkeratotic papules on the trunk and extremities.\u00a0Diagnosis relies on combining clinical presentation,\u00a0histopathological findings, and exclusion of similar conditions. Treatment remains challenging, focusing on immunomodulatory agents to mitigate inflammation and disease progression. While therapies may not reverse existing cicatricial damage, early intervention can slow further hair loss and papule formation. Patient education on treatment goals fosters compliance and maintains strong patient-physician relationships.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Pearls and Other Issues. GLPLS is a complex clinical\u00a0entity presenting with multifocal, patchy cicatricial scalp alopecia, noncicatricial\u00a0alopecia in areas like the axillae and perineum, and hyperkeratotic papules on the trunk and extremities.\u00a0Diagnosis relies on combining clinical presentation,\u00a0histopathological findings, and exclusion of similar conditions. Treatment remains challenging, focusing on immunomodulatory agents to mitigate inflammation and disease progression. While therapies may not reverse existing cicatricial damage, early intervention can slow further hair loss and papule formation. Patient education on treatment goals fosters compliance and maintains strong patient-physician relationships."}
{"id": "article-22386_27", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional approach involving various medical specialties is essential for the comprehensive evaluation and management of GLPLS. Dermatologists, dermatopathologists, pharmacists, hair-loss support groups, and psychologists play crucial roles in diagnosis and long-term care. Besides ensuring accurate diagnosis, trained professionals and alopecia support groups offer vital psychosocial support, fostering a sense of belonging and reducing stress associated with a GLPLS diagnosis. [28]", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Enhancing Healthcare Team Outcomes. An interprofessional approach involving various medical specialties is essential for the comprehensive evaluation and management of GLPLS. Dermatologists, dermatopathologists, pharmacists, hair-loss support groups, and psychologists play crucial roles in diagnosis and long-term care. Besides ensuring accurate diagnosis, trained professionals and alopecia support groups offer vital psychosocial support, fostering a sense of belonging and reducing stress associated with a GLPLS diagnosis. [28]"}
{"id": "article-22386_28", "title": "Graham-Little-Piccardi-Lasseur Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Graham-Little-Piccardi-Lasseur Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}